Most computational binder design aims at a single target, but therapeutic applications increasingly call for multispecific molecules: bispecific engagers, multi-target inhibitors, and conditional logic gates. Scaffold engineering is the discipline of designing protein frameworks that can accommodate multiple binding functions without mutual interference.
A successful multispecific scaffold must satisfy several constraints:
- Thermodynamic stability: the scaffold must tolerate surface mutations without unfolding. AffiniBind™ screens scaffolds with ΔG_folding ≤ −8 kcal/mol.
- Structural rigidity: flexible scaffolds allow paratope cross-talk; rigid frameworks maintain independent binding.
- Accessible surface area: sufficient solvent-exposed area to accommodate multiple binding interfaces.
- Expression yield: the final multispecific construct must express solubly in a production host (typically E. coli or HEK293).
≤ −8ΔG_folding (kcal/mol)
≥ 25 ÅParatope Separation
4–6Max Paratopes/Scaffold
Three strategies for placing multiple binding functions on a single scaffold:
Fusing binding domains at the N- and C-termini of a central scaffold. Simplest to implement but risks inter-domain steric clash.
Introducing binding residues onto opposite faces of a symmetric scaffold (e.g., a homodimer or symmetric β-barrel). Provides spatial separation but constrains scaffold choice.
Replacing solvent-exposed loops with binding-competent sequences. Enables up to 4–6 independent paratopes on a single scaffold but requires careful loop-length optimization.
The key challenge in multispecific design is preventing paratope A from interfering with paratope B:
- Electrostatic isolation: placing paratopes with opposing charge profiles on separated faces.
- Steric separation: ensuring a minimum center-to-center distance (≥25 Å) between paratope interfaces.
- Folding cooperativity: confirming that individual paratope mutations do not destabilize the scaffold core.
Multispecific binders require compound validation:
- Simultaneous binding: SPR co-injection experiments confirming both targets can bind concurrently.
- No cross-reactivity: each paratope shows no detectable binding to the other's target.
- Stoichiometry confirmation: SEC-MALS or native MS confirming 1:1:1 complex formation.
Scaffold engineering is an active area of development at WeaveSeq. View open targets to see current multispecific design projects.
Related reading: quantifying binding kinetics in complex serum, high-throughput validation of synthetic binders, and our binding-site fingerprinting benchmark.
